Related references
Note: Only part of the references are listed.A multimolecular signaling complex including PrPC and LRP1 is strictly dependent on lipid rafts and is essential for the function of tissue plasminogen activator
Vincenzo Mattei et al.
JOURNAL OF NEUROCHEMISTRY (2020)
Therapeutics targeting the fibrinolytic system
Haili Lin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage
Ariel Diaz et al.
JOURNAL OF NEUROSCIENCE (2020)
Effect of A beta Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons
Marta Rolland et al.
JOURNAL OF NEUROSCIENCE (2020)
Targeting Amyloidogenic Processing of APP in Alzheimer's Disease
Jing Zhao et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration
John L. Robinson et al.
BRAIN (2020)
Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
Siddhartha Mondragon-Rodriguez et al.
NEURAL PLASTICITY (2020)
Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes
Ariel Diaz et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate
Yang He et al.
NATURE COMMUNICATIONS (2019)
The Role of NMDA Receptors in Alzheimer's Disease
Jinping Liu et al.
FRONTIERS IN NEUROSCIENCE (2019)
Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)
Sophie Lenoir et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
The neuropathological diagnosis of Alzheimer's disease
Michael A. DeTure et al.
MOLECULAR NEURODEGENERATION (2019)
Targeting the Synapse in Alzheimer's Disease
Johanna Jackson et al.
FRONTIERS IN NEUROSCIENCE (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications
Francesco Angelucci et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Emma Nichols et al.
LANCET NEUROLOGY (2019)
Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain
Paola Merino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Tissue-type plasminogen activator protects the postsynaptic density in the ischemic brain
Valerie Jeanneret et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention
Jade Marsh et al.
NEURAL REGENERATION RESEARCH (2018)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2018)
THE AMYLOID HYPOTHESIS ON TRAIL
Simon Makin
NATURE (2018)
Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System
Paola Merino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain
Ariel Diaz et al.
JOURNAL OF NEUROSCIENCE (2017)
A clinicopathological approach to the diagnosis of dementia
Fanny M. Elahi et al.
NATURE REVIEWS NEUROLOGY (2017)
Not just amyloid: physiological functions of the amyloid precursor protein family
Ulrike C. Mueller et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke
Weiwen Wu et al.
NEUROLOGICAL RESEARCH (2017)
Physiology and pathophysiology of the plasminogen system in the kidney
Per Svenningsen et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2017)
Physiological and pathological functions of neuroserpin: Regulation of cellular responses through multiple mechanisms
Tet Woo Lee et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony
Stefania Forner et al.
TRENDS IN NEUROSCIENCES (2017)
Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease
Xin Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models
Wei Li et al.
BMC NEUROLOGY (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Neuroserpin Protects Rat Neurons and Microglia-Mediated Inflammatory Response Against Oxygen Glucose Deprivation- and Reoxygenation Treatments in an In Vitro Study
Xuelian Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Tissue-type plasminogen activator is a modulator of the synaptic vesicle cycle
Manuel Yepes
NEURAL REGENERATION RESEARCH (2016)
Amyloid beta modulation of neuronal network activity in vitro
Hamid Charkhkar et al.
BRAIN RESEARCH (2015)
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
Arnaud Chevilley et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
Manuel Yepes
Frontiers in Cellular Neuroscience (2015)
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease
Sergio T. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons
Naomi Mamada et al.
MOLECULAR BRAIN (2015)
Synaptic activity and Alzheimer's disease: a critical update
Davide Tampellini
FRONTIERS IN NEUROSCIENCE (2015)
Neuroprotective Effect of Neuroserpin in Oxygen-Glucose Deprivation- and Reoxygenation-Treated Rat Astrocytes In Vitro
Liang Wang et al.
PLOS ONE (2015)
Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease
R-M Liu et al.
NEUROBIOLOGY OF AGING (2011)
Plasminogen and plasmin in Alzheimer's disease
Rachel Barker et al.
BRAIN RESEARCH (2010)
Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus
Ramiro Echeverry et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop et al.
NATURE NEUROSCIENCE (2010)
Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
Shay Fabbro et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation
MG Medina et al.
EMBO JOURNAL (2005)
Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly
K Yamamoto et al.
CARDIOVASCULAR RESEARCH (2005)
Plasmin Deficiency in Alzheimer's Disease Brains: Causal or Casual?
Carlos G. Dotti et al.
NEURODEGENERATIVE DISEASES (2004)
Amyloid β-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells
J Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior
R Pawlak et al.
NATURE NEUROSCIENCE (2003)
Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, klotho mouse
K Takeshita et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Urokinase-type plasminogen activator inhibits amyloid-β neurotoxicity and fibrillogenesis via plasminogen
HM Tucker et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Serpinopathies and the conformational dementias
DA Lomas et al.
NATURE REVIEWS GENETICS (2002)
Association between conformational mutations in neuroserpin and onset and severity of dementia
RL Davis et al.
LANCET (2002)
Tissue plasminogen activator requires plasminogen to modulate amyloid-β neurotoxicity and deposition
HM Tucker et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Structure of a serpin-protease complex shows inhibition by deformation
JA Huntington et al.
NATURE (2000)
Share Paper
